MDL Centralization Sought for Valsartan Litigation
A motion was recently filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) that seeks to consolidate federal complaints filed with regard to valsartan, a generic hypertension drug. The motion was filed late in October 2018 by Robert Kruk on behalf of himself and other plaintiffs with pending valsartan lawsuits. Kruk... Read more »